Mengis Capital Management, Inc. Eli Lilly & CO Transaction History
Mengis Capital Management, Inc.
- $487 Million
- Q2 2024
A detailed history of Mengis Capital Management, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Mengis Capital Management, Inc. holds 7,399 shares of LLY stock, worth $6.49 Million. This represents 1.38% of its overall portfolio holdings.
Number of Shares
7,399
Previous 7,474
1.0%
Holding current value
$6.49 Million
Previous $6.77 Million
1.01%
% of portfolio
1.38%
Previous 1.06%
Shares
18 transactions
Others Institutions Holding LLY
# of Institutions
3,872Shares Held
751MCall Options Held
6.34MPut Options Held
7.97M-
Lilly Endowment Inc Indianapolis, IN97.4MShares$85.4 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA73.9MShares$64.8 Billion1.31% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$57.8 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$45.1 Billion31.1% of portfolio
-
State Street Corp Boston, MA33.9MShares$29.7 Billion1.36% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $834B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...